Xenosys Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 370.40%
- Profit Growth 302.53%
- Ebitda 45.24%
- Net Worth 144.17%
- Total Assets 241.49%
About Xenosys Biotech
Xenosys Biotech Private Limited (XBPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 September 2020 (Four years and five months 5 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jagat Srivastava and Prakash Kumar serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24110GJ2020PTC116385
-
Company No.
116385
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Sep 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
What products or services does Xenosys Biotech Private Limited offer?
Xenosys Biotech Private Limited offers a wide range of products and services, including Common Disease Medicines, Allopathic Cough Syrup, Sexual Wellness Products, Female Hygiene Products & Test Kits, Respiratory System Drugs, Anti Asthma Drug, Nutraceuticals & Dietary Supplements, Multivitamin Syrup & Drops, Pharmaceutical Medicine, Digestive System Drugs & Medicines.
Who are the key members and board of directors at Xenosys Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jagat Srivastava
|
Director | 10-Sep-2020 | Current |
|
Prakash Kumar
|
Director | 10-Sep-2020 | Current |
Financial Performance of Xenosys Biotech.
Xenosys Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 370.4% increase. The company also saw a substantial improvement in profitability, with a 302.53% increase in profit. The company's net worth Soared by an impressive increase of 144.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Xenosys Biotech?
Unlock access to Xenosys Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Budjug Pharma Private LimitedJagat Srivastava is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Xenosys Biotech?
Xenosys Biotech has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Xenosys Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Xenosys Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.